Once-Monthly Galcanezumab for the Prevention of Migraine in Adults: An Evidence-Based Descriptive Review and Potential Place in Therapy

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s159690
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cariprazine for Acute and Maintenance Treatment of Adults With Schizophrenia: An Evidence-Based Review and Place in Therapy

Neuropsychiatric Disease and Treatment
2018English

Transarterial Chemoembolization for Hepatocellular Carcinoma: An Evidence-Based Review of Its Place in Therapy

Journal of Hepatocellular Carcinoma
2015English

Adalimumab in Ankylosing Spondylitis: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Rasburicase in the Management of Tumor Lysis: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2015English

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Pain and Therapy
NeurologyAnesthesiologyPain Medicine
2020English

Galcanezumab: A Monoclonal Antibody for Migraine Prophylaxis

Prescriber
Pharmacology
2020English

Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Review of Emerging Therapy in Refractory GERD- An Evidence Based Approach

Gastroenterology & Hepatology: Open Access
2018English

Palbociclib: An Evidence-Based Review of Its Potential in the Treatment of Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy